Are PBMs Really the Problem with American Healthcare? | TWE 188
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Are PBMs Really the Problem with American Healthcare? | TWE 188
-
ナレーター：
-
著者：
Will cracking down on healthcare middlemen make your prescriptions more affordable?
In This Week’s Economy 188, economist Vance Ginn examines pharmacy benefit managers, the services they perform, and the incentives shaping America’s healthcare system.
The episode asks what happens to drug-price negotiations and benefit administration when policymakers restrict intermediaries, why a reform that helps one business may still raise costs for patients, and how competition and greater patient control could improve the system.
PBMs deserve scrutiny. Every proposed replacement does, too.
Before another mandate, ask: Who benefits? Who pays? Who gets to choose?
Follow the podcast, leave a rating and review, and share this episode with someone navigating healthcare costs.
Full episode show notes + newsletter subscription:
https://vanceginn.substack.com/p/b088f5ee-12b3-41c3-b728-39a49f510819
Research and policy guides:
https://vanceginn.com